<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28832798</article-id><article-id pub-id-type="pmc">5570388</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2016-0081</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Avoiding Liver Injury with Papaverine and Ascorbic Acid Due to
Infrarenal Cross-Clamping: an Experimental Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Huseyin</surname><given-names>Serhat</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Guclu</surname><given-names>Orkut</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Y&#x000fc;ksel</surname><given-names>Volkan</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Erkul</surname><given-names>Gulen Sezer Alptekin</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Can</surname><given-names>Nuray</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Turan</surname><given-names>Fatma Nesrin</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Canbaz</surname><given-names>Suat</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1">
<label>1</label> Department of Cardiovascular Surgery of Trakya University School of
Medicine, Edirne, Turkey.</aff><aff id="aff2">
<label>2</label> Department of Medical Pathology of Trakya University School of
Medicine, Edirne, Turkey.</aff><aff id="aff3">
<label>3</label> Department of Biostatistics of Trakya University School of
Medicine, Edirne, Turkey.</aff><author-notes><corresp id="c1">Correspondence Address: Serhat Huseyin Trakya, University School of
Medicine, Department of Cardiovascular Surgery, 22030, Edirne, Turkey. E-mail:
<email>serhathuseyin@hotmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>May-Jun</season><year>2017</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>May-Jun</season><year>2017</year></pub-date><volume>32</volume><issue>3</issue><fpage>197</fpage><lpage>201</lpage><history><date date-type="received"><day>26</day><month>12</month><year>2016</year></date><date date-type="accepted"><day>24</day><month>1</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>Ischemia-reperfusion injury after acute ischemia treatment is a serious
condition with high mortality and morbidity. Ischemia-reperfusion injury may
result in organ failure particularly in kidney, lung, liver, and heart. In
our study, we investigated the effects of papaverine and vitamin C on
ischemia-reperfusion injury developed in the rat liver after
occlusion-reperfusion of rat aorta.</p></sec><sec><title>Methods</title><p>32 Sprague-Dawley female rats were randomized into four groups (n=8).
Ischemia was induced with infrarenal aortic cross-clamping for 60 minutes;
then the clamp was removed and reperfusion was allowed for 120 minutes.
While the control group and the ischemia-reperfusion group did not receive
any supplementary agent, two other groups received vitamin C and papaverine
hydrochloride (papaverine HCL). Liver tissues were evaluated under the light
microscope. Histopathological examination was assessed by Suzuki's criteria
and results were compared between groups.</p></sec><sec><title>Results</title><p>In ischemia-reperfusion group, severe congestion, severe cytoplasmic
vacuolization, and parenchymal necrosis over 60% (score 4) were observed. In
vitamin C group, mild congestion, mild cytoplasmic vacuolization and
parenchymal necrosis below 30% (score 2) were found. In papaverine group,
moderate congestion, moderate cytoplasmic vacuolization and parenchymal
necrosis below 60% (score 3) were observed.</p></sec><sec><title>Conclusion</title><p>An ischemia of 60 minutes induced on lower extremities causes damaging
effects on hepatic tissue. Vitamin C and papaverine are helpful in reducing
liver injury after acute ischemia reperfusion and may partially avoid
related negative conditions.</p></sec></abstract><kwd-group><kwd>Reperfusion Injury</kwd><kwd>Liver Diseases</kwd><kwd>Papaverine</kwd><kwd>Ascorbic Acid</kwd><kwd>Rats</kwd><kwd>Models, Animal</kwd></kwd-group></article-meta></front><body><table-wrap id="t3" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">I-R</td><td align="left" rowspan="1" colspan="1">= Ischemia-reperfusion</td></tr><tr><td align="left" rowspan="1" colspan="1">Papaverine HCL</td><td align="left" rowspan="1" colspan="1">= Papaverine hydrochloride</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Ischemia develops during aortic surgery due to aortic clamping in lower extremities
and the following reperfusion process brings about a systemic inflammatory response
that causes endothelial injury and increasing vascular permeability. Non-cardiac
pulmonary dysfunction can be indicated in many patients following an elective aorta
surgery and is an important cause of postoperative morbidity<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. During reperfusion, many chemical
mediators are released into systemic circulation due to washout effect and
contribute to distal organ injuries by organ capillary occlusions through possible
microembolies<sup>[<xref rid="r2" ref-type="bibr">2</xref>-<xref rid="r4" ref-type="bibr">4</xref>]</sup>. Those result with increased
permeability, platelet aggregation and necrotic areas due to microvascular
endothelial injury in major organs<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>. This condition caused pulmonary edema and microproteinuria in
the kidney. On the other hand, the effects of distal organ ischemia-reperfusion
(I-R) injury on liver are examined in a limited number of studies.</p><p>Many treatment strategies have been developed to prevent and to reduce I-R injury. As
vitamin C (ascorbic acid) has long been known for its antioxidant effect and
papaverine has vasodilator effects, we assume that vitamin C and papaverine could
reverse the vasoconstrictive effects of the chemical mediators released during
systemic inflammatory response and may reduce I-R injury in hepatic
tissue<sup>[<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p><p>The aim of the present study is to perform a histopathological examination of the
effects of vitamin C and papaverine on liver tissues following I-R injury in lower
extremities.</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Study Design</title><p>The study was performed in Experimental Animals Laboratory after the approval by
Local Ethic Committee was obtained (Number: 36/2012). Thirty-two female
Sprague-Dawley rats, 3.5-4 months old and weighing about 190-250 g, were used.
The animals were randomly divided into four groups (n=8). This experimental
study was carried out in accordance with Animals Act and associated guidelines.
All animals were handled in accordance with the Guide for the Care and Use of
Laboratory Animals.</p></sec><sec><title>Preparation of the animals and the surgical techniques</title><p>All animals were given ketamin HCl 40 mg/kg (Ketalar<sup>&#x000ae;</sup> 50 mg/ml
vial, Pfizer Drug Company, Istanbul, Turkey) + xylazine hydrochloride 5 mg/kg
(Rompun<sup>&#x000ae;</sup> 23.32 mg/ml, 50 ml vial, Bayer Drug Company,
Istanbul, Turkey) after 8 hours fasting, with intramuscular anesthesia into left
foot muscle, ensuring spontaneous respiration during the procedure. The animals
were placed in a supine position on the table under a radiant heater. After the
area of the skin aseptically prepared, all animals were subjected to median
laparotomy from right below the xiphoid to 0.5 cm above pubis; intestines were
deviated to the right side, then the infrarenal abdominal aorta and liver were
explored through a blunt dissection. All animals were given a low dose (100
unites/kg) of heparin (Nevparin<sup>&#x000ae;</sup> 25000 IU 5 ml flakon, Mustafa
Nevzat Drug Company, Istanbul, Turkey). Fluid resuscitation was supplied with 10
ml/kg 0.9% NaCl through the tail vein. Infrarenal abdominal aorta was clamped
with an atraumatic microvascular clamp (Novaclip<sup>&#x000ae;</sup> 12 mm Angle,
Plymouth, USA). After clamping, 5 ml warm saline solution was injected into the
peritoneal cavity. To prevent abdominal fluid loss, the skin area was
approximated with a suture. After 60 minutes of ischemia, clamp was removed and
we waited 2 hours for reperfusion. Ischemia was monitored by loss of pulsation
in aorta and reperfusion was monitored by the presence of pulsation in aorta.
The animals were sacrificed after the procedure, and the livers of all animals
were removed and conserved in 10% formalin.</p></sec><sec><title>Experimental Groups</title><sec><title>Control Group (Group 1) (n=8)</title><p>Rats hepatectomised at the end of the targeted period without any other
procedure following anesthesia and median laparotomy.</p></sec><sec><title>Ischemia-Reperfusion Group (Group 2) (n=8)</title><p>Rats hepatectomised at the end of the targeted ischemia-reperfusion duration
with induced ischemia-reperfusion following a standard surgical
procedure.</p></sec><sec><title>Ischemia-Reperfusion + Vitamin C group (Group 3) (n=8)</title><p>Rats with induced ischemia following a standard surgical procedure, started
infusion with 50 mg/kg dose of vitamin C (ascorbic acid)
(Redoxan<sup>&#x000ae;</sup> 500 mg/5 ml vial, Bayer Drug Company,
Istanbul, Turkey) 15 minutes before declamping and hepatectomised at the end
of the reperfusion duration.</p></sec><sec><title>Ischemia-Reperfusion + Papaverine Group (Group 4) (n=8)</title><p>Rats with induced ischemia following a standard surgical procedure, and
started infusion with 1.5 mg/kg dose of papaverine HCl (Papaverin
HCl<sup>&#x000ae;</sup> 0.05 g/ 2 ml, Galen Drug Company, Istanbul,
Turkey) 15 minutes before declamping, and hepatectomised at the end of the
reperfusion duration.</p></sec></sec><sec><title>Histopathological Examination</title><p>Liver tissues were fixed separately in 10% buffered neutral formalin, and tissue
monitoring was performed. From the samples, paraffin blocks were prepared and
4-5 &#x000b5;m sections were cut and stained with hematoxylin and eosin (H+E).
Histopathological examinations were performed under a light microscope.
Sinusoidal congestion, hepatocyte cytoplasm vacuolization and parenchymal
necrosis were assessed as described by Suzuki et al.<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup> and scored on a scale from 0 to 4 (<xref ref-type="table" rid="t1">Table 1</xref>).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Suzuki scoring scale.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Score</th><th align="center" rowspan="1" colspan="1">Congestion</th><th align="center" rowspan="1" colspan="1">Cytoplasmic vacuolization</th><th align="center" rowspan="1" colspan="1">Parenchymal necrosis</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">No</td></tr><tr><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">Minimal</td><td align="center" rowspan="1" colspan="1">Minimal</td><td align="center" rowspan="1" colspan="1">Single-cell necrosis</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">&#x0003c; 30%</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">Moderate</td><td align="center" rowspan="1" colspan="1">Moderate</td><td align="center" rowspan="1" colspan="1">&#x0003c; 60%</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">Severe</td><td align="center" rowspan="1" colspan="1">Severe</td><td align="center" rowspan="1" colspan="1">&#x0003e; 60%</td></tr></tbody></table></table-wrap></sec><sec><title>Statistical Analysis</title><p>Statistical evaluations were performed using Statistical Package for the Social
Sciences 20 (SPSS Inc, Chicago, IL, USA) and, for multiple comparisons, Kruskal
Wallis analysis of variance and Bonferroni corrected Mann-Whitney U test were
used. Descriptive statistics were median (min-max) values. Level of significance
was accepted as <italic>P</italic>&#x02264;0.05; two-way and
<italic>P</italic>&#x02264;0.008 for Bonferroni correction.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>In our study, we used Suzuki classification in assessments and while no pathological
differences were observed in the livers of three animals (Suzuki score 0), minimal
congestion, minimal cytoplasmic vacuolization, and single-cell necrosis were
observed in five animals (Suzuki score 1) in Group 1 (<xref ref-type="fig" rid="f1">Figures 1A</xref> and <xref ref-type="fig" rid="f1">B</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>A) Group 1 subject 1, score 0: regular hepatic histology. B) Group 1
subject 8, score 1: sinusoidal congestion findings. C) Group 2 subject
6, score 4: marked congestion, extensive cytoplasmic vacuolization,
focal cellular necrosis. D) Group 4 subject 5, score 2: sinusoidal
congestion, mild level of cytoplasmic vacuolization. E) Group 4 subject
6. score 3: moderate level of congestion and cytoplasmic
vacuolization.</p></caption><graphic xlink:href="rbccv-32-03-0197-g01"/></fig>
</p><p>In Group 2, minimal congestion, minimal cytoplasmic vacuolization, and single-cell
necrosis were observed in three rats (Suzuki score 1); mild congestion, mild
cytoplasmic vacuolization and parenchymal necrosis below 30% were observed in two
rats (Suzuki score 2); moderate congestion, moderate cytoplasmic vacuolization, and
parenchymal necrosis below 60% were observed in two rats (Suzuki score 3); severe
congestion, severe cytoplasmic vacuolization, and parenchymal necrosis above 60%
were observed in one rat (Suzuki score 4) (<xref ref-type="fig" rid="f1">Figure
1C</xref>).</p><p>In Group 3, while no histopathological difference in the liver (Suzuki score 0) was
observed in one animal, there were minimal congestion, minimal cytoplasmic
vacuolization, and single-cell necrosis (Score 1) in five animals, and mild
congestion, mild cytoplasmic vacuolization and parenchymal necrosis below 30% (score
2) in two animals (<xref ref-type="fig" rid="f1">Figure 1D</xref>).</p><p>In Group 4, although the histopathological examination of the liver revealed no
difference (score 0), minimal congestion, minimal cytoplasmic vacuolization, and
single-cell necrosis were observed in four animals (Score 1); mild congestion, mild
cytoplasmic vacuolization, and parenchymal necrosis below 30% were observed in two
animals (Score 2); and moderate congestion, moderate cytoplasmic vacuolization and
parenchymal necrosis below 60% were observed (Score 3) in one animal (<xref ref-type="fig" rid="f1">Figure 1E</xref>).</p><p>There was a statistically significant difference among the groups Suzuki scores
(<italic>P</italic>=0.021). In pairwise comparisons, while a significant
difference (<italic>P</italic>=0.007) between Group 1 and Group 2 was found, the
comparisons among other groups did not reveal any significant difference
(respectively; Group 1 with Group 3, and with Group 4; <italic>P</italic>=0.195;
0.105; Group 2 with Groups 3 and 4; <italic>P</italic>=0.083, 0.234; with Group 2
and Group 3; <italic>P</italic>=0.645). In other words, although similar
histopathological values were obtained in the comparison of Groups 3 and 4 with
Group 1 and of Group 3 with Group 4, the histopathological scores were lower in
Group 1 in comparison to Group 2 (<italic>P</italic>=0.007) (<xref ref-type="table" rid="t2">Table 2</xref>, <xref ref-type="fig" rid="f2">Figure 2</xref>).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Histopathological scores by groups.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="center" rowspan="1" colspan="1">Median</th><th align="center" rowspan="1" colspan="1">Minimum</th><th align="center" rowspan="1" colspan="1">Maximum</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Control (n=8)</td><td align="center" rowspan="1" colspan="1">10.000</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Ischemia-reperfusion (n=8)</td><td align="center" rowspan="1" colspan="1">20.000</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">4.00</td></tr><tr><td align="left" rowspan="1" colspan="1">I-R +Vit C (n=8)</td><td align="center" rowspan="1" colspan="1">10.000</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2.00</td></tr><tr><td align="left" rowspan="1" colspan="1">I-R+ Papaverine (n=8)</td><td align="center" rowspan="1" colspan="1">10.000</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">3.00</td></tr></tbody></table></table-wrap><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Histopathological scores by groups.</p></caption><graphic xlink:href="rbccv-32-03-0197-g02"/></fig>
</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Infrarenal abdominal aortic surgery for abdominal aortic aneurysm and peripheric
bypass surgery have remained the gold standard treatment despite the decreasing
number of such procedure with the development of endovascular techniques<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. I-R experiments constitute the
experimental models simulating injuries developed following such organ surgeries,
circulation shocks, and disseminated intravascular coagulation disorders<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. Aortic clamping procedure used
in abdominal aortic surgery is not an innocent procedure, as it is well known. Not
only its local effects, but also the systemic effects contribute to this fact. In
patients with peripheral arterial disease, who have abnormal microvascular
perfusion, oxygen increase during reperfusion is higher and therefore, ischemic
injury is more severe<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. For
this reason, antioxidant agents to reduce the injury are being tested in
experimental models which otherwise require a long processes to clinical
application<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>.</p><p>In this study, we used ascorbic acid, because it is the strongest antioxidant soluble
in water. We also used papaverine, an opium alkaloid and a good vasodilator that is
thought to have an antioxidant effect through inhibition of mitochondrial glutamate
oxidase system for decreasing oxidative stress and lipid peroxidation<sup>[<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref>-<xref rid="r13" ref-type="bibr">13</xref>]</sup>. We found that
ascorbic acid and papaverine caused some decrease in I-R related histopathological
injury, although not reaching a statistically significant level. Various studies
have addressed the use of similar agents in similar durations and their beneficial
effects. In experimental studies on rats, reperfusion of distal organ ischemia has
been shown to cause injury in lungs, kidneys, and in small intestine, and the use of
certain molecules, such as melatonin, oxytocin, ascorbic acid and complement
inhibitors, has reductive effects on the injuries<sup>[<xref rid="r14" ref-type="bibr">14</xref>-<xref rid="r22" ref-type="bibr">22</xref>]</sup>.
Strategies directed at reducing apoptosis are thought to improve survival after
ischemia and reduce reperfusion injury<sup>[<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r23" ref-type="bibr">23</xref>]</sup>.</p><p>We need to look at the pathophysiological process, caused by the condition in lower
limbs. Skeletal muscle of the lower limbs is the major tissue that is susceptible to
ischemia. Irreversible muscle injury starts after 3 hours of ischemia and complete
at the 6<sup>th</sup> hour<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>.
Mortality and amputation rates in acute peripheric arterial occlusion have been
reported as 10-25% and 20%, respectively. Duration of ischemia has great importance
among the factors that affect mortality and morbidity<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>. Free oxygen radicals, TNF-alpha and other
mediators released into circulation during I-R activate various proteins involved in
apoptosis. This causes DNA damage and cell death<sup>[<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r23" ref-type="bibr">23</xref>]</sup>. The more affected tissue mass
and duration of ischemia, the more severe are the complications<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>.</p><p>The effects of I-R injury occur after 45 minutes in lungs and after 60 minutes of
ischemia in extremities during reperfusion<sup>[<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r26" ref-type="bibr">26</xref>,<xref rid="r27" ref-type="bibr">27</xref>]</sup>. The tolerable duration of normothermic hepatic
ischemia is not known and thought that irreversible injury occurs after 90 minutes
of elective liver surgery<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>.
However, there is a limited number of clinical and experimental studies on distal
organ I-R-related liver injury. In literature, there two studies that have reported
the histopathological and biochemical effects of distal organ ischemia reperfusion
on liver<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>. Based on similar
studies, we planned to use I-R duration as 60 minutes of ischemia and 120 minutes of
reperfusion<sup>[<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r16" ref-type="bibr">16</xref>]</sup>. We also demonstrated in our
study that 60 minutes of ischemia and 120 minutes of reperfusion induced in lower
limbs of healthy subjects caused a significant I-R injury in hepatic tissue
histopathologically.</p><p>However, clinical studies have shown that the liver injury occurred in this part is
influenced by many other factors, from hepatic lipid content to various systemic
factors like acute hyperglycemia<sup>[<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r23" ref-type="bibr">23</xref>]</sup>. Sprung et al.<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup>, in their clinical study on 942
consecutive patients who had elective abdominal aortic aneurysm and vasculopathy,
found an acute increase in hepatic enzymes in 1.5% of the patients at 24-72 hours
postoperatively. However, we did not analyze the effects of the systemic factors on
our subjects due to limited technical resources. This is a limitation in our study.
Another limitation is that the subjects in our study do not have any vasculopathy
and systemic risk factors, unlike real patient population.</p><p>Initiation time of the antioxidant agents is also important. Since the free radicals
formation has shown to occur rapidly (in the first seconds of the reperfusion), it
has been known that the use of free radical scavengers is only effective when it is
initiated 15 minutes prior to reperfusion if it is to reduce the reperfusion injury,
and it has not any protective effect when initiated after reperfusion<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r29" ref-type="bibr">29</xref>]</sup>. In our study, distal ischemia was also induced and at 45
minutes of ischemia, that is, 15 minutes before reperfusion antioxidant agent was
initiated and the histopathological results were analyzed by using Suzuki
classification<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>.
Although similar histopathological values were obtained in the comparison of Group 3
and Group 4 with Group 1 and Group 3 with Group 4, the histopathological scores were
lower in the control group in comparison with Group 2. In other words, Group 4 and
Group 3 revealed similar results, yet the level of injury in these groups were lower
compared to Group 2, although not statistically significant. In addition, Andrews et
al.<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup> demonstrated that,
in experimental ischemia model in the gastric mucosa before reperfusion, the use of
agents that increase gastric blood flow and vasodilator papaverine do not have any
beneficial effect on I-R injury. These findings suggest that papaverine may have
different effects depending on the type of ischemia, or on the organ involved. In
another study, Ko&#x000e7;arslan et al.<sup>[<xref rid="r31" ref-type="bibr">31</xref>]</sup> showed that intraperitoneal administration of silymarin
reduces oxidative stress and protects liver, kidney, and lungs from acute
supraceliac abdominal aorta ischemia-reperfusion injury in the rat model.
Pharmacological, genetic and surgical studies directed at decreasing I-R injury
would elucidate the prospect to decrease mortality and morbidity caused by vascular
diseases and surgeries.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>In conclusion, we revealed that an ischemia of 60 minutes induced on lower limbs is
sufficient to cause damaging effects on hepatic tissue. We conclude that both
papaverine and ascorbic acid, given 15 minutes prior to reperfusion, reduced hepatic
injury caused by reperfusion following ischemia in lower limbs in experimental
conditions.</p><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">SH</td><td align="left" rowspan="1" colspan="1">Conception and design study; conduct of procedures
and/or experiments; writing of the manuscript or review of its
content; final manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">OG</td><td align="left" rowspan="1" colspan="1">Analysis and/or data interpretation; final manuscript
approval</td></tr><tr><td align="left" rowspan="1" colspan="1">VY</td><td align="left" rowspan="1" colspan="1">Manuscript redaction or critical review of its content;
final manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">GSAE</td><td align="left" rowspan="1" colspan="1">Analysis and/or data interpretation; final manuscript
approval</td></tr><tr><td align="left" rowspan="1" colspan="1">NC</td><td align="left" rowspan="1" colspan="1">Pathological examination; final manuscript
approval</td></tr><tr><td align="left" rowspan="1" colspan="1">FNT</td><td align="left" rowspan="1" colspan="1">Statistical analysis; final manuscript approval</td></tr><tr><td align="left" rowspan="1" colspan="1">SC</td><td align="left" rowspan="1" colspan="1">Critical review of its content; final manuscript
approval</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at the Trakya University School of Medicine, Edirne,
Turkey.</p></fn><fn fn-type="supported-by"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>FC</given-names></name><name><surname>Gosling</surname><given-names>P</given-names></name><name><surname>Sanghera</surname><given-names>K</given-names></name><name><surname>Green</surname><given-names>MA</given-names></name><name><surname>Paterson</surname><given-names>IS</given-names></name><name><surname>Shearman</surname><given-names>CP</given-names></name></person-group><article-title>Microproteinuria predicts the severity of systemic effects of
reperfusion injury following infrarenal aortic aneurysm
surgery</article-title><source>Ann Vasc Surg</source><year>1994</year><volume>8</volume><issue>1</issue><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">8192991</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colletti</surname><given-names>LM</given-names></name><name><surname>Kunkel</surname><given-names>SL</given-names></name><name><surname>Walz</surname><given-names>A</given-names></name><name><surname>Burdick</surname><given-names>MD</given-names></name><name><surname>Kunkel</surname><given-names>RG</given-names></name><name><surname>Wilke</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Chemokine expression during hepatic ischemia/reperfusion-induced
lung injury in the rat. The role of epithelial neutrophil activating
protein</article-title><source>J Clin Invest</source><year>1995</year><volume>95</volume><issue>1</issue><fpage>134</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">7814607</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goksin</surname><given-names>I</given-names></name><name><surname>Akbulut</surname><given-names>M</given-names></name><name><surname>Baltalarli</surname><given-names>A</given-names></name><name><surname>Sacar</surname><given-names>M</given-names></name><name><surname>Kaya</surname><given-names>S</given-names></name><name><surname>Ozcan</surname><given-names>V</given-names></name><etal/></person-group><article-title>The effect of normovolemic hemodilution on lung injury after
ischemia-reperfusion of lower extremities</article-title><source>Turkish J Thorac Cardiovasc Surg.</source><year>2006</year><volume>14</volume><issue>1</issue><fpage>54</fpage><lpage>58</lpage></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sirin</surname><given-names>H</given-names></name><name><surname>Saribulbul</surname><given-names>O</given-names></name><name><surname>Cerrahoglu</surname><given-names>M</given-names></name><name><surname>Aksoy</surname><given-names>O</given-names></name><name><surname>Baltalarli</surname><given-names>A</given-names></name><name><surname>Sacar</surname><given-names>M</given-names></name><etal/></person-group><article-title>Protective effect of aprotinin on lung injury caused by
ischemia-reperfusion of the lower extremities</article-title><source>Turkish J Thorac Cardiovasc Surg</source><year>2001</year><volume>9</volume><fpage>233</fpage><lpage>237</lpage></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saba</surname><given-names>D</given-names></name><name><surname>Yavuz</surname><given-names>H</given-names></name><name><surname>Senkaya</surname><given-names>I</given-names></name><name><surname>Agris</surname><given-names>M</given-names></name><name><surname>Ozer</surname><given-names>Z</given-names></name><name><surname>Ozkan</surname><given-names>H</given-names></name><etal/></person-group><article-title>The effects of calcium dobesilate on skeletal muscle
ischemia</article-title><source>Turkish J Thorac Cardiovasc Surg</source><year>2000</year><volume>8</volume><fpage>797</fpage><lpage>801</lpage></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serracino-Inglott</surname><given-names>F</given-names></name><name><surname>Habib</surname><given-names>NA</given-names></name><name><surname>Mathie</surname><given-names>RT</given-names></name></person-group><article-title>Hepatic ischemia-reperfusion injury</article-title><source>Am J Surg</source><year>2001</year><volume>181</volume><issue>2</issue><fpage>160</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">11425059</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montalvo-Jave</surname><given-names>EE</given-names></name><name><surname>Escalante-Tattersfield</surname><given-names>T</given-names></name><name><surname>Ortega-Salgado</surname><given-names>JA</given-names></name><name><surname>Pi&#x000f1;a</surname><given-names>E</given-names></name><name><surname>Geller</surname><given-names>DA</given-names></name></person-group><article-title>Factors in the pathophysiology of the liver ischemiareperfusion
injury</article-title><source>J Surg Res</source><year>2008</year><volume>147</volume><issue>1</issue><fpage>153</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">17707862</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>S</given-names></name><name><surname>Nakamura</surname><given-names>S</given-names></name><name><surname>Koizumi</surname><given-names>T</given-names></name><name><surname>Sakaguchi</surname><given-names>S</given-names></name><name><surname>Baba</surname><given-names>S</given-names></name><name><surname>Muro</surname><given-names>H</given-names></name><etal/></person-group><article-title>The beneficial effect of a prostaglandin I2 analog on ischemic
rat liver</article-title><source>Transplantation</source><year>1991</year><volume>52</volume><issue>6</issue><fpage>979</fpage><lpage>983</lpage><pub-id pub-id-type="pmid">1750084</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yavuz</surname><given-names>S</given-names></name><name><surname>Ozbudak</surname><given-names>E</given-names></name><name><surname>Gumusta</surname><given-names>S</given-names></name><name><surname>Kanko</surname><given-names>M</given-names></name><name><surname>Ciftci</surname><given-names>E</given-names></name><name><surname>Berki</surname><given-names>T</given-names></name></person-group><article-title>Endovascular stent-graft applications in abdominal aortic
aneurysms: mid- and long-term results</article-title><source>Turkish J Thorac Cardiovasc Surg</source><year>2013</year><volume>21</volume><fpage>333</fpage><lpage>340</lpage></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adingupu</surname><given-names>DD</given-names></name><name><surname>Thorn</surname><given-names>CE</given-names></name><name><surname>Casanova</surname><given-names>F</given-names></name><name><surname>Elyas</surname><given-names>S</given-names></name><name><surname>Gooding</surname><given-names>K</given-names></name><name><surname>Gilchrist</surname><given-names>M</given-names></name><etal/></person-group><article-title>Blood oxygen saturation after ischemia is altered with abnormal
microvascular reperfusion</article-title><source>Microcirculation</source><year>2015</year><volume>22</volume><issue>4</issue><fpage>294</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">25737352</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salman</surname><given-names>E</given-names></name><name><surname>Bayraktaroglu</surname><given-names>M</given-names></name><name><surname>Dogan</surname><given-names>OV</given-names></name><name><surname>Yorukoglu</surname><given-names>Y</given-names></name><name><surname>Yucel</surname><given-names>E</given-names></name><name><surname>Kosebalaban</surname><given-names>S</given-names></name><etal/></person-group><article-title>Use of ascorbic acid in open heart surgery as an oxygen free
radical scavenger</article-title><source>Turkish J Thorac Cardiovasc Surg</source><year>1994</year><volume>2</volume><fpage>216</fpage><lpage>220</lpage></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandra</surname><given-names>R</given-names></name><name><surname>Aneja</surname><given-names>R</given-names></name><name><surname>Rewal</surname><given-names>C</given-names></name><name><surname>Konduri</surname><given-names>R</given-names></name><name><surname>Dass</surname><given-names>SK</given-names></name><name><surname>Agarwal</surname><given-names>S</given-names></name></person-group><article-title>An opium alkaloid-papaverine ameliorates ethanol-induced
hepatotoxicity: diminution of oxidative stress</article-title><source>Indian J Clin Biochem</source><year>2000</year><volume>15</volume><issue>2</issue><fpage>155</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">23105258</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urakov</surname><given-names>AL</given-names></name><name><surname>Baranov</surname><given-names>AG</given-names></name></person-group><article-title>Effect of papaverine on the energy processes of myocardial
mitochondria</article-title><source>Farmakol Toksikol</source><year>1979</year><volume>42</volume><issue>2</issue><fpage>132</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">437079</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uysal</surname><given-names>A</given-names></name><name><surname>Burma</surname><given-names>O</given-names></name><name><surname>Akar</surname><given-names>I</given-names></name><name><surname>Ozsin</surname><given-names>KK</given-names></name><name><surname>Rahman</surname><given-names>A</given-names></name><name><surname>Ustundag</surname><given-names>B</given-names></name><etal/></person-group><article-title>Protective effect of melatonin on lung injury caused by
ischemia-reperfusion of the lower extremities</article-title><source>Turkish J Thorac Cardiovasc Surg</source><year>2006</year><volume>14</volume><fpage>308</fpage><lpage>314</lpage></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isbir</surname><given-names>S</given-names></name><name><surname>Akgun</surname><given-names>S</given-names></name><name><surname>Ak</surname><given-names>K</given-names></name><name><surname>Civelek</surname><given-names>A</given-names></name><name><surname>Tekeli</surname><given-names>A</given-names></name><name><surname>Cobanoglu</surname><given-names>A</given-names></name><etal/></person-group><article-title>Effect of acute lower limb ischemia / reperfusion injury on the
free oxygen radical systems in lungs</article-title><source>Turkish J Thorac Cardiovasc Surg</source><year>2000</year><volume>8</volume><fpage>632</fpage><lpage>634</lpage></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ka&#x000e7;maz</surname><given-names>A</given-names></name><name><surname>User</surname><given-names>EY</given-names></name><name><surname>Sehirli</surname><given-names>AO</given-names></name><name><surname>Tilki</surname><given-names>M</given-names></name><name><surname>Ozkan</surname><given-names>S</given-names></name><name><surname>Sener</surname><given-names>G</given-names></name></person-group><article-title>Protective effect of melatonin against
ischemia/reperfusion-induced oxidative remote organ injury in the
rat.</article-title><source>Surg Today</source><year>2005</year><volume>35</volume><issue>9</issue><fpage>744</fpage><lpage>750</lpage><pub-id pub-id-type="pmid">16133669</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oktar</surname><given-names>GL</given-names></name><name><surname>Demir Amac</surname><given-names>N</given-names></name><name><surname>Elmas</surname><given-names>C</given-names></name><name><surname>Arslan</surname><given-names>M</given-names></name><name><surname>Goktas</surname><given-names>G</given-names></name><name><surname>Iriz</surname><given-names>E</given-names></name><etal/></person-group><article-title>The histopathological effects of levosimendan on liver injury
induced by myocardial ischemia and reperfusion</article-title><source>Bratisl Lek Listy</source><year>2015</year><volume>116</volume><issue>4</issue><fpage>241</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">25773952</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tas Hekimoglu</surname><given-names>A</given-names></name><name><surname>Toprak</surname><given-names>G</given-names></name><name><surname>Akkoc</surname><given-names>H</given-names></name><name><surname>Evliyaoglu</surname><given-names>O</given-names></name><name><surname>Ozekinci</surname><given-names>S</given-names></name><name><surname>Kelle</surname><given-names>I</given-names></name></person-group><article-title>Oxytocin ameliorates remote liver injury induced by renal
ischemia-reperfusion in rats</article-title><source>Korean J Physiol Pharmacol</source><year>2013</year><volume>17</volume><issue>2</issue><fpage>169</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">23626480</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>FC</given-names></name><name><surname>Gosling</surname><given-names>P</given-names></name><name><surname>Sanghera</surname><given-names>K</given-names></name><name><surname>Green</surname><given-names>MA</given-names></name><name><surname>Paterson</surname><given-names>IS</given-names></name><name><surname>Shearman</surname><given-names>CP</given-names></name></person-group><article-title>Microproteinuria predicts the severity of systemic effects of
reperfusion injury following infrarenal aortic aneurysm
surgery</article-title><source>Ann Vasc Surg</source><year>1994</year><volume>8</volume><issue>1</issue><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">8192991</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takhtfooladi</surname><given-names>H</given-names></name><name><surname>Takhtfooladi</surname><given-names>M</given-names></name><name><surname>Moayer</surname><given-names>F</given-names></name><name><surname>Mobarakeh</surname><given-names>S</given-names></name></person-group><article-title>Melatonin attenuates lung injury in a hind limb
ischemia-reperfusion rat model</article-title><source>Rev Port Pneumol</source><year>2015</year><volume>21</volume><issue>1</issue><fpage>30</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">25854133</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yassin</surname><given-names>MM</given-names></name><name><surname>Barros D'Sa</surname><given-names>AA</given-names></name><name><surname>Parks</surname><given-names>G</given-names></name><name><surname>Abdulkadir</surname><given-names>AS</given-names></name><name><surname>Halliday</surname><given-names>I</given-names></name><name><surname>Rowlands</surname><given-names>BJ</given-names></name></person-group><article-title>Mortality following lower limb ischemia-reperfusion: a systemic
inflammatory response?</article-title><source>World J Surg</source><year>1996</year><volume>20</volume><issue>8</issue><fpage>961</fpage><lpage>966</lpage><pub-id pub-id-type="pmid">8798348</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berkan</surname><given-names>O</given-names></name><name><surname>Y&#x00131;ld&#x00131;z</surname><given-names>E</given-names></name><name><surname>Katranc&#x00131;oglu</surname><given-names>N</given-names></name><name><surname>Gunay</surname><given-names>I</given-names></name></person-group><article-title>Effect of ascorbic acid in the lung injury caused by ischemia
reperfusion of the lower extremities</article-title><source>Turkish J Thorac Cardiovasc Surg</source><year>2001</year><volume>9</volume><fpage>238</fpage><lpage>241</lpage></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montalvo-Jave</surname><given-names>EE</given-names></name><name><surname>Escalante-Tattersfield</surname><given-names>T</given-names></name><name><surname>Ortega-Salgado</surname><given-names>JA</given-names></name><name><surname>Pi&#x000f1;a</surname><given-names>E</given-names></name><name><surname>Geller</surname><given-names>DA</given-names></name></person-group><article-title>Factors in the pathophysiology of the liver ischemiareperfusion
injury</article-title><source>J Surg Res</source><year>2008</year><volume>147</volume><issue>1</issue><fpage>153</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">17707862</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaisdell</surname><given-names>FW</given-names></name></person-group><article-title>The pathophysiology of skeletal muscle ischemia and the
reperfusion syndrome: a review</article-title><source>Cardiovasc Surg</source><year>2002</year><volume>10</volume><issue>6</issue><fpage>620</fpage><lpage>630</lpage><pub-id pub-id-type="pmid">12453699</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000fc;ler</surname><given-names>A</given-names></name><name><surname>Sahin</surname><given-names>MA</given-names></name><name><surname>Karabacak</surname><given-names>K</given-names></name><name><surname>K&#x000fc;&#x000e7;&#x000fc;kaslan</surname><given-names>N</given-names></name><name><surname>Yokusoglu</surname><given-names>M</given-names></name><name><surname>Tatar</surname><given-names>H</given-names></name></person-group><article-title>Accompanying embolectomy and closed fasciotomy in the same
session for the delayed arterial thromboembolic occlusions in lower
extremity</article-title><source>Anadolu Kardiyol Derg</source><year>2009</year><volume>9</volume><issue>5</issue><fpage>407</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">19819793</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paller</surname><given-names>MS</given-names></name><name><surname>Hoidal</surname><given-names>JR</given-names></name><name><surname>Ferris</surname><given-names>TF</given-names></name></person-group><article-title>Oxygen free radicals in ischemic acute renal failure in the
rat</article-title><source>J Clin Invest</source><year>1984</year><volume>74</volume><issue>4</issue><fpage>1156</fpage><lpage>1164</lpage><pub-id pub-id-type="pmid">6434591</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dosluoglu</surname><given-names>HH</given-names></name><name><surname>Aktan</surname><given-names>AO</given-names></name><name><surname>Yegen</surname><given-names>C</given-names></name><name><surname>Okboy</surname><given-names>N</given-names></name><name><surname>Yal&#x000e7;m</surname><given-names>AS</given-names></name><name><surname>Yahn</surname><given-names>R</given-names></name><etal/></person-group><article-title>The cytoprotective effects of verapamil and iloprost (ZK 36374)
on ischemia/reperfusion injury of kidneys</article-title><source>Transpl Int</source><year>1993</year><volume>6</volume><issue>3</issue><fpage>138</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">7684589</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sprung</surname><given-names>J</given-names></name><name><surname>Levy</surname><given-names>PJ</given-names></name><name><surname>Tabares</surname><given-names>AH</given-names></name><name><surname>Gottlieb</surname><given-names>A</given-names></name><name><surname>Schoenwald</surname><given-names>PK</given-names></name><name><surname>Olin</surname><given-names>JW</given-names></name></person-group><article-title>Ischemic liver dysfunction after elective repair of infrarenal
aortic aneurysm: incidence and outcome</article-title><source>J Cardiothorac Vasc Anesth</source><year>1998</year><volume>12</volume><issue>5</issue><fpage>507</fpage><lpage>511</lpage><pub-id pub-id-type="pmid">9801968</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JL</given-names></name><name><surname>Lucchesi</surname><given-names>BR</given-names></name></person-group><article-title>Mechanisms of myocardial reperfusion injury</article-title><source>Ann Thorac Surg</source><year>1999</year><volume>68</volume><issue>5</issue><fpage>1905</fpage><lpage>1912</lpage><pub-id pub-id-type="pmid">10585102</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>FJ</given-names></name><name><surname>Malcontenti-Wilson</surname><given-names>C</given-names></name><name><surname>O'Brien</surname><given-names>PE</given-names></name></person-group><article-title>Protection against gastric ischemia-reperfusion injury by nitric
oxide generators</article-title><source>Dig Dis Sci</source><year>1994</year><volume>39</volume><issue>2</issue><fpage>366</fpage><lpage>373</lpage><pub-id pub-id-type="pmid">8313820</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko&#x000e7;arslan</surname><given-names>A</given-names></name><name><surname>Ko&#x000e7;arslan</surname><given-names>S</given-names></name><name><surname>Aydin</surname><given-names>MS</given-names></name><name><surname>Gunay</surname><given-names>S</given-names></name><name><surname>Karahan</surname><given-names>MA</given-names></name><name><surname>Taskin</surname><given-names>A</given-names></name><etal/></person-group><article-title>Intraperitoneal administration of silymarin protects end organs
from multivisceral &#x00131;schemia/reperfusion &#x00131;njury in a rat
model</article-title><source>Braz J Cardiovasc Surg</source><year>2016</year><volume>31</volume><issue>6</issue><fpage>434</fpage><lpage>439</lpage><pub-id pub-id-type="pmid">28076620</pub-id></element-citation></ref></ref-list></back></article>